Potent urea and carbamate inhibitors of soluble epoxide hydrolases.
about
Identification and functional characterization of human soluble epoxide hydrolase genetic polymorphismsToxicology in the fast lane: application of high-throughput bioassays to detect modulation of key enzymes and receptorsIn vitro biologic activities of the antimicrobials triclocarban, its analogs, and triclosan in bioassay screens: receptor-based bioassay screensInvestigation of human exposure to triclocarban after showering and preliminary evaluation of its biological effectsThe soluble epoxide hydrolase encoded by EPXH2 is a bifunctional enzyme with novel lipid phosphate phosphatase activityLipid sulfates and sulfonates are allosteric competitive inhibitors of the N-terminal phosphatase activity of the mammalian soluble epoxide hydrolaseSoluble epoxide hydrolase as a therapeutic target for cardiovascular diseasesDiscovery of inhibitors of soluble epoxide hydrolase: a target with multiple potential therapeutic indicationsImpact of soluble epoxide hydrolase and epoxyeicosanoids on human healthEvaluation of fish models of soluble epoxide hydrolase inhibitionDetoxification of environmental mutagens and carcinogens: structure, mechanism, and evolution of liver epoxide hydrolaseBinding of alkylurea inhibitors to epoxide hydrolase implicates active site tyrosines in substrate activationInhibition of soluble epoxide hydrolase by fulvestrant and sulfoxidesOptimized inhibitors of soluble epoxide hydrolase improve in vitro target residence time and in vivo efficacyFragment Screening of Soluble Epoxide Hydrolase for Lead Generation-Structure-Based Hit Evaluation and Chemistry ExplorationEET signaling in cancerTriclocarban enhances testosterone action: a new type of endocrine disruptor?Soluble epoxide hydrolase inhibitors and heart failureRational Design of Potent and Selective Inhibitors of an Epoxide Hydrolase Virulence Factor from Pseudomonas aeruginosaSoluble epoxide hydrolase plays an essential role in angiotensin II-induced cardiac hypertrophySoluble epoxide hydrolase expression in a porcine model of arteriovenous graft stenosis and anti-inflammatory effects of a soluble epoxide hydrolase inhibitorPharmacokinetic optimization of four soluble epoxide hydrolase inhibitors for use in a murine model of inflammationSoluble epoxide hydrolase gene deletion attenuates renal injury and inflammation with DOCA-salt hypertensionInhibition of soluble epoxide hydrolase contributes to the anti-inflammatory effect of antimicrobial triclocarban in a murine modelThe 2014 Bernard B. Brodie award lecture-epoxide hydrolases: drug metabolism to therapeutics for chronic painDevelopment of an HTS assay for EPHX2 phosphatase activity and screening of nontargeted librariesSoluble epoxide hydrolase in atherosclerosisAn immunoassay to evaluate human/environmental exposure to the antimicrobial triclocarbanEpoxides and soluble epoxide hydrolase in cardiovascular physiologyPharmacokinetic screening of soluble epoxide hydrolase inhibitors in dogsBeneficial effects of soluble epoxide hydrolase inhibitors in myocardial infarction model: Insight gained using metabolomic approachesPotent natural soluble epoxide hydrolase inhibitors from Pentadiplandra brazzeana baillon: synthesis, quantification, and measurement of biological activities in vitro and in vivoAttenuation of tobacco smoke-induced lung inflammation by treatment with a soluble epoxide hydrolase inhibitorDevelopment of a high-throughput screen for soluble epoxide hydrolase inhibitionBrassica napus soluble epoxide hydrolase (BNSEH1).Fluorescent substrates for soluble epoxide hydrolase and application to inhibition studies.The 5-substituted piperazine as a novel secondary pharmacophore greatly improving the physical properties of urea-based inhibitors of soluble epoxide hydrolaseEH3 (ABHD9): the first member of a new epoxide hydrolase family with high activity for fatty acid epoxides.Symmetric adamantyl-diureas as soluble epoxide hydrolase inhibitors.Inhibition of soluble epoxide hydrolase by trans-4- [4-(3-adamantan-1-yl-ureido)-cyclohexyloxy]-benzoic acid is protective against ischemia-reperfusion injury.
P2860
Q22254318-6EBF804A-DF0E-4356-9AC2-E017D3F4427EQ23911122-7AC30CD6-7AED-4AA6-A3CB-95469991BE17Q23916239-340E23B1-1234-4040-BCB3-4BD4029D650EQ23918896-5B1994E3-2774-4547-9784-13122A6C8951Q24294384-7C0AFF51-B14F-4DE6-83EF-465C8D8121DDQ24546215-E83D87A8-5ABC-46AA-871F-AD1C6D25D14AQ24597172-A0423B90-5D05-4DCA-9096-14B849A7BA6FQ24616753-21FEF493-D778-463A-881D-1050E61FBB29Q24618018-57153318-19F5-4B39-982B-9A9CAECB5FD4Q24812965-9A708F85-B9B5-40BB-8B9F-A6D892B03774Q27619610-2DB30B2E-751A-48EA-9F79-B1EEEDDA5ABFQ27622060-02B36872-C175-427A-B638-8470FAF85DFDQ27678172-C59E67A9-288D-4297-BA1A-67B5362DB5FEQ27684895-899C5D9E-76D0-4914-834A-0A9466CF0B21Q27703977-FDCC0B07-6888-4364-A7D0-90B6720FF77FQ28250730-3C8E213B-23F4-459D-8728-A116F4E0108AQ28259283-FBCCAD6A-DB79-402D-80C0-BF2761E20D18Q28383423-D02EE6BE-B096-4F82-B606-0B660C5B63EDQ28384766-986B01F5-5B0F-43FA-BA83-0CEB78E3C4EFQ28387081-D9509194-C31A-4B5D-A716-0E07B2BE2CD5Q28387686-3BE19D7F-8E86-4E27-B511-DFAC413257B3Q28389323-F0672247-251D-439F-8D73-70873A84C43FQ28390972-12FFE345-438C-49B7-8B9D-3F68047DE0FDQ28391172-85277762-F52F-438C-918A-A4A617FD5ED2Q28392416-80FB0940-91B4-43CE-8FE0-5BD19752465AQ28393751-D729A9E2-D97D-4BF5-A4E9-3D85760FE616Q28395004-B749E68E-3181-4EF9-8A08-8F15D7C1B59CQ28395553-EE485D95-75D1-4487-9C55-E4270FD0FC1BQ28396313-50A1C0C1-A81E-4558-8620-0A5279178FFDQ28396888-A1144495-C5B0-4E6C-9569-66476A445923Q28397084-56E0DD03-5DCA-4990-842C-91DD47F6E2D8Q28543232-7A4DC262-B185-4A7D-8BC6-443E65E6658FQ28571602-07A50179-D822-41BF-B574-FC506F28B8C4Q30816822-36782C35-E43A-4C37-BFA2-60A1F56F79DFQ33184938-539B7931-EBE1-41FF-82FD-ADB7999D3C3FQ33217361-A8151517-3352-40CB-B3F6-48E59B9AB8E3Q33247246-B5F6DAEA-5BCF-41AC-A809-C2F402215232Q33288850-DA12BB6E-966E-4091-99DA-E8A069F90C4DQ33605509-B975E3C9-BA24-4F22-BB8D-BA4C2FE73026Q33665713-A1248A86-E487-4F82-9795-0AEA313CB81B
P2860
Potent urea and carbamate inhibitors of soluble epoxide hydrolases.
description
1999 nî lūn-bûn
@nan
1999年の論文
@ja
1999年論文
@yue
1999年論文
@zh-hant
1999年論文
@zh-hk
1999年論文
@zh-mo
1999年論文
@zh-tw
1999年论文
@wuu
1999年论文
@zh
1999年论文
@zh-cn
name
Potent urea and carbamate inhibitors of soluble epoxide hydrolases.
@ast
Potent urea and carbamate inhibitors of soluble epoxide hydrolases.
@en
type
label
Potent urea and carbamate inhibitors of soluble epoxide hydrolases.
@ast
Potent urea and carbamate inhibitors of soluble epoxide hydrolases.
@en
prefLabel
Potent urea and carbamate inhibitors of soluble epoxide hydrolases.
@ast
Potent urea and carbamate inhibitors of soluble epoxide hydrolases.
@en
P2093
P2860
P356
P1476
Potent urea and carbamate inhibitors of soluble epoxide hydrolases.
@en
P2093
B D Hammock
C Morisseau
J F Greene
J R Sanborn
M H Goodrow
P2860
P304
P356
10.1073/PNAS.96.16.8849
P407
P577
1999-08-01T00:00:00Z